DENTSPLY SIRONA Inc. (XRAY)’s Shares Are Flat Since Cramer Commented On Them

We recently published Jim Cramer’s Biggest Losers: 10 Stocks That Just Didn’t Work Out. DENTSPLY SIRONA Inc. (NASDAQ:XRAY) is one of the stocks discussed by Jim Cramer.

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) is a dental products manufacturer. Its shares are down by 26.9% over the past year and are up by 3.4% year-to-date. Soon after Cramer discussed the firm, it reported its fourth quarter earnings on February 26th. The results saw DENTSPLY SIRONA Inc. (NASDAQ:XRAY) post $961 million in revenue and $0.27 in earnings per share. Through these, the firm beat analyst revenue estimates but missed them for earnings. DENTSPLY SIRONA Inc. (NASDAQ:XRAY)’s shares closed 15.5% higher on February 27th. On May 6th, the shares closed 2% lower on the day after the firm had reported its first quarter earnings and posted a 39% annual earnings-per-share drop. Here is what Cramer said about DENTSPLY SIRONA Inc. (NASDAQ:XRAY) on January 6th in his appearance on Mad Money:

DENTSPLY SIRONA Inc. (XRAY)’s Shares Are Flat Since Cramer Commented On Them

“You know, do you know that this used to be a very expensive growth company, and now it is worth very little? And I think it absolutely represents some value here. I’m glad you brought it to my attention. I’m going to suggest that you buy some and put it away.”

While we acknowledge the risk and potential of XRAY as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than XRAY and that has 10,000% upside potential, check out our report about the cheapest AI stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy.

Disclosure: None. Follow Insider Monkey on Google News.

1281292 - 11759070 - 1